Portfolio Diversification
Range
Most Diversified
20 instruments
January 1, 2022
Least Diversified
0 instruments
February 2, 2025
Average
19.7 instruments
Most Consistent Holdings
Top 5
JNJ99.92%
MRK99.92%
PFE99.92%
MRNA99.92%
NVAX99.92%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Vaxcyte (PCVX) | 6.59% | 2.7% | 99.54% | - |
| Merck (MRK) | 6.56% | 5.27% | 99.92% | - |
 Arcturus Therapeutics (ARCT) | 6.19% | 6.87% | 99.92% | - |
| Novavax (NVAX) | 5.97% | 5.48% | 99.92% | - |
| Moderna (MRNA) | 5.79% | 3.48% | 99.92% | - |
| Johnson & Johnson (JNJ) | 5.57% | 7.23% | 99.92% | - |
 Dynavax (DVAX) | 5.52% | 4.51% | 99.92% | - |
 Sanofi (SNY) | 5.41% | 4.13% | 99.54% | - |
 BioNTech SE (BNTX) | 5% | 6.48% | 99.92% | - |
 Vir (VIR) | 4.87% | 2.94% | 99.92% | - |
| Pfizer (PFE) | 4.69% | 4.38% | 99.92% | - |
 Abbott (ABT) | 4.24% | 5.93% | 73.48% | - |
 CureVac (CVAC) | 4.15% | 6.56% | 99.92% | - |
 AstraZeneca (AZN) | 3.84% | 6.09% | 73.48% | - |
 Agenus (AGEN) | 3.07% | 0% | 81.17% | 1/2/2025 |
 GlaxoSmithKline (GSK) | 2.67% | 0% | 52.74% | 12/28/2023 |
 Emergent BioSolutions (EBS) | 2.56% | 3.25% | 71.88% | - |
 Maravai (MRVI) | 2.27% | 2.53% | 46.8% | - |
 Vaxart (VXRT) | 2.06% | 2.27% | 45.2% | - |
 Valneva (VLA.PA) | 1.93% | 7.06% | 47.18% | - |
 Inovio (INO) | 1.44% | 0% | 53.13% | 12/28/2023 |
 CanSino Biologics (6185.HK) | 1.33% | 0% | 28.35% | 1/2/2025 |
 CSL (CSL.ASX) | 1.1% | 0% | 27.97% | 1/1/2025 |
 Takeda (TAK) | 1.01% | 0% | 26.68% | 12/28/2023 |
 OPKO Health (OPK) | 0.94% | 0% | 28.05% | 1/2/2025 |
 Bavarian Nordic A/S (BAVA.CO) | 0.88% | 5.96% | 18.75% | - |
 Personalis (PSNL) | 0.79% | 4.26% | 18.75% | - |
 Allovir (KLRS) | 0.79% | 0% | 26.45% | 1/5/2023 |
 Invivyd (IVVD) | 0.74% | 0% | 26.07% | 1/5/2023 |
 VBI Vaccines (VBIVQ) | 0.68% | 0% | 26.45% | 1/5/2023 |
 GSK (GSK.L) | 0.02% | 0% | 0.38% | 1/5/2022 |
 Sanofi (SAN.PA) | 0.02% | 0% | 0.38% | 1/5/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Vaxcyte (PCVX) | 1.88% | 9.9% |
| Novavax (NVAX) | 15.45% | 8.86% |
| CanSino Biologics (6185.HK) | 3.53% | 7.58% |
| BioNTech SE (BNTX) | 6.83% | 6.35% |
| Abbott (ABT) | 3.67% | 5.93% |
| Merck (MRK) | 2.91% | 5.78% |
| Johnson & Johnson (JNJ) | 4.28% | 5.67% |
| AstraZeneca (AZN) | 3.35% | 5.01% |
| Dynavax (DVAX) | 2.91% | 4.91% |
| Maravai (MRVI) | 3.73% | 4.85% |
| Sanofi (SNY) | 2.87% | 4.38% |
| Pfizer (PFE) | 5.25% | 4.34% |
| Vir (VIR) | 7.69% | 4.3% |
| CSL (CSL.ASX) | 2.69% | 4.19% |
| OPKO Health (OPK) | 2.73% | 4.05% |
| CureVac (CVAC) | 8.22% | 3.88% |
| Arcturus Therapeutics (ARCT) | 3.58% | 3.83% |
| Moderna (MRNA) | 7.03% | 2.14% |
| Valneva (VLA.PA) | 2.71% | 2.1% |
| Agenus (AGEN) | 8.06% | 0.95% |